How are investors using prediction markets to inform investment decisions?
Dr. David Katz, President and CEO of Diet ID, joins Double Take to examine how GLP-1s may affect far more than weight loss—from food noise and addiction to healthcare costs, side effects and shifts in consumer behavior across sectors.
The podcast is intended for investment professionals ONLY and should not be construed as investment advice or a recommendation. Any stock examples discussed are given in the context of the theme being explored and the views expressed are those of the presenters at the time of recording.
LISTEN ON
